Used as a key intermediate in the synthesis of tadalafil, a pharmaceutical agent for treating erectile dysfunction and benign prostatic hyperplasia. It plays a critical role in the formation of the pyrazinoisoquinoline core structure during manufacturing. Due to its reactive functional groups, it enables selective chemical transformations necessary for building the final active molecule. Primarily utilized in controlled laboratory and industrial settings for API production, not intended for direct therapeutic use.